Ignite Creation Date:
2024-05-05 @ 7:25 PM
Last Modification Date:
2024-10-26 @ 9:48 AM
Study NCT ID:
NCT00669994
Status:
COMPLETED
Last Update Posted:
2014-12-19
First Post:
2008-04-29
Brief Title:
Trial to Evaluate the Efficacy and Safety of Cipro XR in Treating Female Patients With Lower Urinary Tract Infections
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
Prospective Open Label Non-comparative Multi-center Trial to Evaluate the Efficacy and Safety of Cipro XR 500 mg Once Daily for 3 Days in Treating Female Patients With Acute Uncomplicated Symptomatic Lower Urinary Tract Infections
Status:
COMPLETED
Status Verified Date:
2014-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This trial evaluated how effective and safe Cipro XR was in treating female patients with signs and symptoms of a lower urinary tract infections After 3 days of treatment patients were evaluated to determine if signssymptoms disappeared and the infecting bacteria was eliminated
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None